Interview in transkript magazine: The treasure trove is open
We are happy to share the interview from the latest transkript magazine about Indivumed's extended company set-up and focus on its own R&D activities.
)
Interview in transkript magazine 2/25
"Die Schatzkiste ist geöffnet - Unlocking the treasure trove". That's how the German transkript magazine titles the interview with our CEO Prof. Dr. Hartmut Juhl and our CBO Dr. Matthias Evers.
They met in April to talk about the recent developments at Indivumed: An extended leadership and full focus on its patient-centric R&D platform to discover, validate, and develop novel targets into first-in-class therapeutics.
Questions were raised on how the biotech and pharma market evolve with its challenges and potentials. They discussed how Indivumed's experience can help achieving the overall goal, the value of partnerships and collaboration and about the importance of disease understanding for a successful development of innovative cancer therapeutics.
We are happy to share the article printed in Biocom's German transkript magazine and featured online in the Euopean Biotechnology magazine.